Preventice Solutions Receives Frost & Sullivan Award for Product Line Strategy Leadership in Remote Cardiac Monitoring

MINNEAPOLIS, Sept. 20, 2017 /PRNewswire/ -- Preventice Solutions announced today it received the 2017 Frost & Sullivan Product Line Strategy Leadership Award for its remote cardiac monitoring portfolio of technologies and services. Following an analysis of the remote cardiac monitoring industry in North America, Frost & Sullivan selected Preventice for the award based on the company's commitment to leveraging product strategies to enhance customer value and experience, going beyond short-term impact on revenues.

In the time of performance based reimbursement, Preventice offers innovative remote monitoring technologies and services that support the diagnosis of cardiac arrhythmias and create a seamless connection between patients and providers. The company's portfolio includes wearable monitors, such as the BodyGuardian^® Heart, and diagnostic monitoring services, including data transmission, surveillance, reporting, interpretation and integration into a physician's workflow via interoperability with electronic medical record (EMR) platforms.

"Preventice is an emerging industry leader for cardiac remote patient monitoring that provides a comprehensive solution for physicians and patients alike," said Patrick Riley, MBA, MHA, CHE, Frost & Sullivan Principal Analyst. "Preventice Solutions offers its own Independent Diagnostic and Testing Facility that provides physicians 24/7 access to patient arrhythmia data. Using Preventice's BodyGuardian^® Remote Monitoring System helps physicians see into their patients' experience — the what and when — which helps them refine their care."

For the Product Line Strategy Leadership Award, Frost & Sullivan analysts independently evaluated Product Line Strength (breadth, scalability, technology leverage, etc.) and Customer Impact (price/performance value, customer experience, etc.).

"We are proud to receive this recognition from Frost & Sullivan for our commitment to addressing customer value and experience with our advanced technologies and services for remote cardiac monitoring," said Jon Otterstatter, Chief Executive Officer, Preventice. "Our focus from the beginning has been on understanding and addressing physician and patient needs with a comprehensive portfolio of monitoring technologies and services. For physicians, it means access to data on how their patients are doing, and for patients, it's technology that allows them to go about their daily activities without restrictions."

Preventice designed a customizable and configurable platform to enable arrhythmia monitoring.  The architecture readily extends to allow remote monitoring using different types of devices. The scalability, security, and extensibility requirements imbedded in the design create the foundation of a chronic care platform that can be used for a range of clinical solutions.

Preventice started as a software company focused on developing practical solutions by actively listening to clinician and patient problems that need to be solved quickly. The Preventice development team responded with a powerful system designed to deliver clinical data in near real-time to clinicians, while making it easy for patients to use the monitor at home, work or throughout their daily activities. Patient mobility, ease of use and simplicity were keys to an effective solution.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.

About BodyGuardian^® Heart

BodyGuardian^® Heart is a small lightweight wireless monitor that records important physiological data such as heart rhythm, ECG, respiratory rate and related activity. Through Bluetooth^®, and other approved technology, the smartphone can also capture additional physiological measurements such as blood-oxygen, glucose levels, blood pressure and weight, anytime anywhere. The system creates a virtual connection between patients and their care teams, allowing physicians to monitor vital signs outside the clinical setting, while patients go about their daily lives.

The data is captured by BodyGuardian^® Heart in near real-time, and the programmatic triage, created based upon the physician's care protocol, can improve care delivery and lower costs. The Preventice monitoring center team analyzes, summarizes, and can ultimately empower clinicians to timely data-driven clinical decisions using an integrated EMR data management system.

About Preventice Solutions

Preventice Solutions is a leading developer of mobile health solutions and remote monitoring services that connect patients threatened by cardiac arrhythmias. Using insights to create revolutionary monitoring technologies, this tech-enabled, service-based approach can ultimately reduce the cost of care and improve health outcomes. Preventice wearable portfolio includes the PatientCare Platform and BodyGuardian^® family. For more information please visit www.preventicesolutions.com

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion

SOURCE Preventice Solutions

Related Links

http://www.preventicesolutions.com